Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Dong K, Liu Z, Li Z, et al. Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv Mater. 2013;25(32):4452–4458.
   PubMed Web of Science ®Google Scholar
• Li ZY, Hu JJ, Xu Q, et al. A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. J Mater Chem B. 2015;3(1):39–44.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313–327.
   PubMed Web of Science ®Google Scholar
• Seo JW, Ang J, Mahakian LM, et al. Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma. J Control Release. 2015;220(Pt A):51–60.
   PubMedGoogle Scholar
• Chen Y, Chen H, Shi J. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells. Mol Pharm. 2014;11(8):2495–2510.
   PubMed Web of Science ®Google Scholar
• Asefa T, Tao Z. Biocompatibility of mesoporous silica nanoparticles. Chem Res Toxicol. 2012;25(11):2265–2284.
   PubMed Web of Science ®Google Scholar
• Chen AM, Zhang M, Wei D, et al. Co-delivery of doxorubicin and bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small. 2009;5(23):2673–2677.
   PubMed Web of Science ®Google Scholar
• Saikia J, Yazdimamaghani M, Hadipour Moghaddam SP, et al. Differential protein adsorption and cellular uptake of silica nanoparticles based on size and porosity. ACS Appl Mater Interfaces. 2016;8(50):34820–34832.
   PubMed Web of Science ®Google Scholar
• Gutierrez JC, Hwang K. The toxicity of methotrexate in male fertility and paternal teratogenicity. Expert Opin Drug Metab Toxicol. 2017;13(1):51–58.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Y, Tian H, et al. Redox-responsive and dual-targeting hyaluronic acid-methotrexate prodrug self-assembling nanoparticles for enhancing intracellular drug self-delivery. Mol Pharm. 2019;16(7):3133–3144.
   PubMedGoogle Scholar
• Giudicessi JR, Ackerman MJ. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res. 2013;161(1):1–14.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Mayer-Kuckuk P, Capiaux G, et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta Mol Basis Dis. 2002;1587(2–3):164–173.
   PubMed Web of Science ®Google Scholar
• Chiarle R, Simmons WJ, Cai H, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005;11(6):623–629.
   PubMed Web of Science ®Google Scholar
• Gao L-F, Xu D-Q, Wen L-J, et al. Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin. 2005;26(3):377–383.
   PubMed Web of Science ®Google Scholar
• Hanafi-Bojd MY, Ansari L, Malaekeh-Nikouei B. Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles. Ther Deliv. 2016;7(9):649–655.
   PubMedGoogle Scholar
• Meng H, Mai WX, Zhang H, et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 2013;7(2):994–1005.
   PubMed Web of Science ®Google Scholar
• Cauda V, Schlossbauer A, Bein T. Bio-degradation study of colloidal mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes and poly (ethylene glycol). Microporous Mesoporous Mater. 2010;132(1–2):60–71.
   Web of Science ®Google Scholar
• Walcarius A, Etienne M, Lebeau B. Rate of access to the binding sites in organically modified silicates. 2. Ordered mesoporous silicas grafted with amine or thiol groups. Chem Mater. 2003;15(11):2161–2173.
   Web of Science ®Google Scholar
• Sun JT, Hong CY, Pan CY. Fabrication of PDEAEMA-coated mesoporous silica nanoparticles and pH-responsive controlled release. J Phys Chem C. 2010;114(29):12481–12486.
   Web of Science ®Google Scholar
• Li X, Chen Y, Wang M, et al. A mesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials. 2013;34(4):1391–1401.
   PubMed Web of Science ®Google Scholar
• Hao N, Jayawardana KW, Chen X, et al. One-step synthesis of amine-functionalized hollow mesoporous silica nanoparticles as efficient antibacterial and anticancer materials. ACS Appl Mater Interfaces. 2015;7(2):1040–1045.
   PubMed Web of Science ®Google Scholar
• Tan WB, Zhang Y. Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications. J Biomed Mater Res A. 2005;75(1):56–62.
   PubMedGoogle Scholar
• Lv G, Qiu L, Liu G, et al. pH sensitive chitosan–mesoporous silica nanoparticles for targeted delivery of a ruthenium complex with enhanced anticancer effects. Dalton Trans. 2016;45(45):18147–18155.
   PubMed Web of Science ®Google Scholar
• Nhavene E, Andrade G, Faria J, et al. Biodegradable polymers grafted onto multifunctional mesoporous silica nanoparticles for gene delivery. ChemEngineering. 2018;2(2):24.
   Google Scholar
• Lin J-T, Liu Z-K, Zhu Q-L, et al. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Colloids Surf B Biointerfaces. 2017;155:41–50.
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Peuhu E, Bate LT, et al. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small. 2010;6(11):1234–1241.
   PubMed Web of Science ®Google Scholar
• Rasouli S, Davaran S, Rasouli F, et al. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Drug Deliv. 2014;21(3):155–163.
   PubMed Web of Science ®Google Scholar
• Shakeran Z, Keyhanfar M, Varshosaz J, et al. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment. Mater Sci Eng C Mater Biol Appl. 2021;118:111526.
   PubMed Web of Science ®Google Scholar
• Meng H, Xue M, Xia T, et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano. 2011;5(5):4131–4144.
   PubMed Web of Science ®Google Scholar
• Mohammad-Beigi H, Yaghmaei S, Roostaazad R, et al. Effect of pH, citrate treatment and silane-coupling agent concentration on the magnetic, structural and surface properties of functionalized silica-coated iron oxide nanocomposite particles. Physica E. 2011;44(3):618–627.
   Google Scholar
• Meng H, Liong M, Xia T, et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano. 2010;4(8):4539–4550.
   PubMed Web of Science ®Google Scholar
• Mooney CM, Jimenez-Mateos EM, Engel T, et al. RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis. Sci Rep. 2017;7:41517.
   PubMed Web of Science ®Google Scholar
• Tarn D, Ashley CE, Xue M, et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc Chem Res. 2013;46(3):792–801.
   PubMed Web of Science ®Google Scholar
• Pedraza D, Díez J, Colilla M, et al. Amine-functionalized MSNs: a new nanoantibiotic for bone infection treatment. Biomed Glass. 2018;3:1–12.
   Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170–183.
   PubMed Web of Science ®Google Scholar
• Lavrič PK, Warmoeskerken MM, Jocic D. Functionalization of cotton with poly-NiPAAm/chitosan microgel. Part I. Stimuli-responsive moisture management properties. Cellulose. 2012;19(1):257–271.
   Web of Science ®Google Scholar
• Hartono SB, Qiao SZ, Liu J, et al. Functionalized mesoporous silica with very large pores for cellulase immobilization. J Phys Chem C. 2010;114(18):8353–8362.
   Web of Science ®Google Scholar
• Lei C, Shin Y, Magnuson JK, et al. Characterization of functionalized nanoporous supports for protein confinement. Nanotechnology. 2006;17(22):5531–5538.
   PubMed Web of Science ®Google Scholar
• Kuruba R, Wilson A, Gao X, et al. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. AAPS J. 2009;11(1):23–30.
   PubMed Web of Science ®Google Scholar
• Briggs L, Russell W. 107. Sophora alkaloids. Part IV. The alkaloids from the seeds of the Chatham Islands species. J Chem Soc. 1942;555–556.
   Google Scholar
• Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, et al. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett. 2013;220(3):286–293.
   PubMed Web of Science ®Google Scholar
• Choi K, Riviere JE, Monteiro-Riviere NA. Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity. Nanotoxicology. 2017;11(1):64–75.
   PubMed Web of Science ®Google Scholar
• Shahabi S, Treccani L, Dringen R, et al. Utilizing the protein corona around silica nanoparticles for dual drug loading and release. Nanoscale. 2015;7(39):16251–16265.
   PubMed Web of Science ®Google Scholar
• Clemments AM, Muniesa C, Landry CC, et al. Effect of surface properties in protein corona development on mesoporous silica nanoparticles. RSC Adv. 2014;4(55):29134–29138.
   Web of Science ®Google Scholar
• Ritz S, Schöttler S, Kotman N, et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules. 2015;16(4):1311–1321.
   PubMed Web of Science ®Google Scholar
• Shen J, Kim HC, Su H, et al. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics. 2014;4(5):487–497.
   PubMed Web of Science ®Google Scholar
• Zhang W, Fang Y, Shi X, et al. Effect of bisphenol a on the EGFR-STAT3 pathway in MCF-7 breast cancer cells. Mol Med Rep. 2012;5(1):41–47.
   PubMed Web of Science ®Google Scholar
• Uchihara Y, Komori R, Tago K, et al. Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells. Biochem Pharmacol. 2019;170:113666.
   PubMed Web of Science ®Google Scholar
• Gremese E, Alivernini S, Tolusso B, et al. JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. J Leukoc Biol. 2019;106(5):1063–1068.
   PubMed Web of Science ®Google Scholar